High-dose, short-term local urokinase for clearing femoral thrombi by vasodilation and thrombolysis.

[1]  D. Silver.  Urokinase in the management of acute arterial and venous thrombosis. , 1968, Archives of surgery.

[2]  A. Quick.  Hemorrhagic diseases and Thrombosis , 1967 .

[3]  W. White,et al.  The isolation and characterization of plasminogen activators (urokinase) from human urine. , 1966, Biochemistry.

[4]  A. Lesuk,et al.  Crystalline Human Urokinase: Some Properties , 1965, Science.

[5]  M. Tsapogas,et al.  EXPERIMENTAL THROMBOLYSIS WITH STREPTOKINASE AND UROKINASE , 1964 .

[6]  M. Tsapogas.  THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS. , 1964, Annals of the Royal College of Surgeons of England.

[7]  E. Cliffton.  The Present Status of Fibrinolytic Therapy , 1963, Angiology.

[8]  A. Quick,et al.  SCREENING FOR BLEEDING STATES--THE PARTIAL THROMBOPLASTIN TEST. , 1963, American journal of clinical pathology.

[9]  G. Markus,et al.  Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme. , 1960, The American journal of physiology.

[10]  P. W. Boyles,et al.  Comparative effectiveness of intravenous and intra-arterial fibrinolysin therapy. , 1960, The American journal of cardiology.

[11]  A. Johnson,et al.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. , 1959, The Journal of clinical investigation.

[12]  A. Fletcher,et al.  The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. , 1959, The Journal of clinical investigation.

[13]  A. Fletcher,et al.  The mechanism of clot dissolution by plasmin. , 1959, The Journal of clinical investigation.

[14]  A. Fletcher,et al.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects. , 1959, The Journal of clinical investigation.

[15]  J. Hagan,et al.  Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid. , 1959, Archives of biochemistry and biophysics.

[16]  A. Fletcher,et al.  xi-Aminocaproic acid: an inhibitor of plasminogen activation. , 1959, The Journal of biological chemistry.

[17]  A. Fletcher,et al.  Fibrinolysis and fibrinolytic activity in man. , 1959, Physiological reviews.

[18]  M. Buckell.  THE EFFECT OF CITRATE ON EUGLOBULIN METHODS OF ESTIMATING FIBRINOLYTIC ACTIVITY , 1958, Journal of clinical pathology.

[19]  T. Astrup,et al.  The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.

[20]  W. Campbell,et al.  THE ALBUMIN, GLOBULINS, AND FIBRINOGEN OF SERUM AND PLASMA , 1937 .

[21]  M. Zinner,et al.  Hemodynamic effects of urokinase in the canine femoral circulation , 1975 .

[22]  E. Freis.  Hypertension. A challenge in preventive cardiology. , 1973, Circulation.

[23]  N. Kjeldgaard,et al.  Urokinase an activator of plasminogen from human urine. I. Isolation and properties. , 1957, Biochimica et biophysica acta.